LITS

AS OF

Dec 24 closing price

Price

$1.39

Change

+$0.02 (+1.46%)

Capitalization

51.13M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

LITS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Lite Strategy (LITS) Ownership - Who owns Lite Strategy?

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Pharmaceuticals Other

Address

N/A

Phone

N/A

Employees

N/A

Web

N/A

Details

Group

Domestic Stock Funds

Fundamentals

LITS

Capitalization

51.1M

P/E Ratio

N/A

Risk (Beta)

1.10

Dividend Yield

N/A

Total Cash

10.1M

Total Cash/Share

0.27

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

112M

P/B Ratio

0.46

Cash Flow

N/A

Earnings

-1.31

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

12.39

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-12.21M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-16.41

Shares Held By Institutions

26.1M

Shares Outstanding - Current

36.8M

Total Liabilities

1.07M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-43.496

View a ticker or compare two or three

Compare

LITS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for LITS

A.I. Advisor

published General Information

General Information

a mfactures pharmaceuticals products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

N/A

Phone

N/A

Employees

N/A

Web

N/A